5F-ADB-PINACA
 | |
| Systematic (IUPAC) name | |
|---|---|
|
N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number | 1801338-21-5 |
| Chemical data | |
| Formula | C19H27FN4O2 |
| Molar mass | 362.5 g/mol |
| |
| |
5F-ADB-PINACA is a cannabinoid designer drug that is an ingredient in some synthetic cannabis products. It is a potent agonist of the CB1 receptor and CB2 receptor with a EC50 value of 0.24 nM and 2.1 nM respectively.[1][2]
Legality
5F-ADB-PINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[3]
See also
References
- ↑ Samuel D Banister, Michael Moir, Jordyn Stuart, Richard C Kevin, Katie E Wood, Mitchell Longworth, Shane M Wilkinson, Corinne Beinat, Alxendra S Buchanan, Michelle Glass, Mark Connor, Iain S McGregor, Michael Kassiou (July 2015). "The pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA and 5F-ADBICA". ACS Chemical Neuroscience 6: 1546–59. doi:10.1021/acschemneuro.5b00112. PMID 26134475.
- ↑ "5F-ADB-PINACA". Cayman Chemical.
- ↑ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 24 July 2015.
This article is issued from Wikipedia - version of the Friday, February 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.